A retrospective, multicenter study to evaluate effect of taxane or vinorelbine combined with trastuzumab and pertuzumab as first line treatment in patients with metastatic breast cancer
Latest Information Update: 24 Jul 2021
At a glance
- Drugs Docetaxel (Primary) ; Paclitaxel (Primary) ; Pertuzumab (Primary) ; Trastuzumab (Primary) ; Vinorelbine (Primary) ; Vinorelbine (Primary)
- Indications Advanced breast cancer; HER2 positive breast cancer
- Focus Therapeutic Use
- 24 Jul 2021 New trial record
- 01 Jul 2021 Results published in the Breast Cancer Research and Treatment